Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

369
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
369
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

590
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
590
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

248
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
248
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Case report: Subcutaneous emphysema following postoperative nausea.

SAGE open medical case reports·2026
Same author

Dental School Biopsy Education to Promote Access to Care and Early Detection.

Journal of dental education·2026
Same author

A Cold World: Pain Outcomes and Patient Experiences Utilizing an Iceless Cold Compression System After Hand Surgery.

Hand (New York, N.Y.)·2026
Same author

Septic Temporomandibular Joint.

The Journal of emergency medicine·2026
Same author

Sterilization of Stainless-Steel Surfaces Using Ultraviolet Radiation Produced by Light-Emitting Diodes.

Astrobiology·2025
Same author

A pediatric patient with mandibular swelling.

Journal of the American Dental Association (1939)·2025

関連する実験動画

Updated: Jan 18, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.5K

再発性虚血性脳卒中：予防戦略

Brian Ford, Michael M Dore, Tyler R Koehn

    American family physician
    |January 16, 2026
    PubMed
    まとめ
    この要約は機械生成です。

    再発性虚血性脳卒中の予防には、心血管系の危険因子の管理と、脳卒中の原因に応じた抗凝固薬や抗血小板療法などの治療法の調整が含まれます。早期発見と介入が、長期的な脳卒中再発リスクを低減する鍵となります。

    キーワード:
    虚血性脳卒中再発予防危険因子抗凝固療法抗血小板療法心血管疾患

    さらに関連する動画

    Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
    09:48

    Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

    Published on: May 4, 2015

    14.2K
    A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
    06:01

    A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

    Published on: August 18, 2015

    15.4K

    関連する実験動画

    Last Updated: Jan 18, 2026

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
    09:21

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

    Published on: January 18, 2018

    12.5K
    Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
    09:48

    Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

    Published on: May 4, 2015

    14.2K
    A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
    06:01

    A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

    Published on: August 18, 2015

    15.4K

    科学分野:

    • 神経学
    • 心臓病学
    • 公衆衛生

    背景:

    • 虚血性脳卒中は、すべての急性脳卒中の87%を占めます。
    • 患者の有意な12%は5年以内に脳卒中の再発を経験しており、効果的な二次予防戦略の必要性が強調されています。

    研究 の 目的:

    • 急性虚血性脳卒中の原因を特定するための診断ツールを概説すること。
    • 脳卒中再発リスクを低減するための管理戦略を詳述すること。

    主な方法:

    • 脳卒中管理に関する確立されたガイドラインと臨床診療のレビュー。
    • 二次脳卒中予防のための主要な危険因子と治療介入の特定。

    主要な成果:

    • 効果的な管理には、高血圧（目標130/80 mm Hg）、スタチン療法、血糖管理、生活習慣の改善（食事、運動、薬物使用の回避）、睡眠時無呼吸症の治療が含まれます。
    • 治療選択は原因特異的です。心房細動関連の塞栓性脳卒中には抗凝固薬、非塞栓性脳卒中には抗血小板療法が使用されます。
    • 頸動脈狭窄管理や卵円孔開存閉鎖などの処置的介入が必要になる場合があります。
    • 脳卒中の原因が不明な場合は、心房細動の長期心臓モニタリングを含むさらなる診断が不可欠です。

    結論:

    • 心血管系の危険因子の包括的な管理は、二次脳卒中予防に不可欠です。
    • 脳卒中の原因に基づいて抗血栓療法を調整し、処置的介入を検討することは、転帰を改善します。
    • 不明な症例における治療の最適化と再発リスクの低減には、徹底的な診断評価が不可欠です。